Planta Med 2003; 69(4): 380-382
DOI: 10.1055/s-2003-38881
Letter
© Georg Thieme Verlag Stuttgart · New York

Glucosinolates in Moringa stenopetala

Yalemtsehay Mekonnen1 , Birgit Dräger1
  • 1Institute of Pharmaceutical Biology, Martin-Luther-Universität Halle-Wittenberg, Halle/Saale, Germany
Further Information

Publication History

Received: August 28, 2002

Accepted: December 15, 2002

Publication Date:
23 April 2003 (online)

Abstract

Bio-guided fractionation of seed extracts from Moringa stenopetala resulted in a myrosinase hydrolysis product, 5,5-dimethyloxazolidine-2-thione. It is formed from the glucosinolate glucoconringiin, which was identified together with O-(rhamnopyranosyloxy)benzyl glucosinolate from M. stenopetala for the first time. The glucosinolates in seeds, leaves and roots of M. stenopetala were quantified as des-sulphoglucosinolate by HPLC. The seeds without testa contained the highest concentration of glucoconringiin and of O-(rhamnopyranosyloxy)benzyl glucosinolate within the plant, 3 % and 19 % of dry mass, respectively.

Abbreviations

GLS:glucosinolate

GC:glucoconringiin

RB-GLS:O-(rhamnopyranosyloxy)benzyl glucosinolate

References

  • 1 Jahn S AA. Using Moringa seeds as coagulants in developing countries.  J Am Water Works Assoc. 1988;  80 43-50
  • 2 Mekonnen Y, Gessesse A. Documentation of the uses of Moringa stenopetala and its possible antileishmanial and antifertility effects.  Ethiop J Sci. 1998;  21 287-95
  • 3 Mekonnen Y, Yardley V, Rock P, Croft S. In vitro antitrypanosomal activity of Moringa stenopetala leaves and roots.  Phytother Res. 1999;  13 538-9
  • 4 Mekonnen Y. Effects of ethanol extract of Moringa stenopetala leaves on guinea-pig and mouse smooth muscle.  Phytothe Res. 1999;  13 442-4
  • 5 Eilert U, Wolters B. Nahrstedt A. The antibiotic principle of seeds of Moringa oleifera and Moringa stenopetala .  Planta Med. 1981;  42 55-61
  • 6 Fahey J W, Zalcmann A T, Talalay P. The chemical diversity and distribution of glucosinolates and isothiocyanates among plants.  Phytochemistry. 2001;  56 5-51
  • 7 Rosa E AS, Heaney R K, Fenwick G R, Porta C AM. Glucosinolate in crop plants.  Horticultural Reviews. 1997;  19 99-215
  • 8 Kjaer A, Malver O, ElMenshari B, Reisch J. Isothiocyantes in myrosinase-treated seed extracts of Moringa peregrina .  Phytochemistry. 1979;  18 1485-7
  • 9 Daxenbichler M E, Spencer G F, Carlson D G, Rose G B, Brinker A M, Powell R G. Glucosinolate composition of seeds from 297 species of wild plants.  Phytochemistry. 1991;  30 2623-38
  • 10 Kiddle G, Bennett R N, Botting N P, Davidson N E, Robertson-Avril A B, Wallsgrove R M. High-performance liquid chromatographic separation of natural and synthetic desulphoglucosinolates and their chemical validation by UV, NMR and chemical ionisation-MS methods.  Phytochem Anal. 2001;  12 226-42
  • 11 Matthaeus B, Luftmann H. Glucosinolates in members of the family Brassicaceae: Separation and identification by LC/ESI-MS-MS.  J Agric Food Chem. 2000;  48 2234-9
  • 12 Badgett B L. Ph. D. Thesis. University of Houston Texas,; cited after Kjaer et al. 1979 (Ref. 8) 1964
  • 13 Muluvi G M, Sprent J I, Soranzo N, Provan J, Odee D, Folkard G, McNicol J W, Powell W. Amplified fragment length polymorphism (AFLP) analysis of genetic variation in Moringa oleifera Lam.  Molecular Ecology. 1999;  8 470
  • 14 Faizi S, Siddiqui B S, Saleem R, Siddiqui S, Aftag K, Gilani A H. Novel hypotensive agents, niazimin A, niazimin B, niazicin A and niazicin B from Moringa oleifera: Isolation of first naturally occuring carbamates. J Chem Soc 1994: 3035-40
  • 15 Faizi S, Siddiqui B S, Saleem R, Aftab K, Shaheen F, Gilani A H. Hypotensive constituents from the pods of Moringa oleifera .  Planta Med. 1998;  64 225-8
  • 16 Murakami A, Kitazono Y, Jiwajinda S, Koshimizu K, Ohigathi H. Niaziminin, a thiocarbamate from the leaves of Moringa oleifera, holds a strict structural requirement for inhibition of tumor-promoter-induced Epstein-Barr virus activation.  Planta Med. 1998;  64 319-23
  • 17 Guevara A P, Vargas C, Sakurai H, Fujiwara Y, Hashimoto K, Maoka T, Kozuka M, Ito Y, Tokuda H, Nishino H. An antitumor promoter from Moringa oleifera Lam.  Mutation Research. 1999;  440 181-8
  • 18 van Poppel G, Verhoeven D T, Verhagen H, Goldbohm R A, Brassica vegetables and cancer p revention. Epidemiology and mechanisms.  Adv Exp Med Biol. 1999;  472 159-68
  • 19 Gassenschmidt U, Jany K D, Tauscher B, Niebergall H. Isolation and characterization of a flocculating protein from Moringa oleifera Lam.  Biochim Biophys Acta. 1995;  1243 477-81
  • 20 Buchner R. Approach to determination of HPLC response factors for glucosinolates. In: Wathelet, J-P, editor World Crops: Production, Utilisation, Description. Vol. 13 Glucosinolates in rapeseeds : Analytical aspects. Boston; Martinuns Nijhoff Publishers 1987: p 50-8

Dr. Birgit Dräger

Institute of Pharmaceutical Biology

Martin-Luther-Universität Halle-Wittenberg

Hoher Weg 8

06120 Halle/Saale

Germany

Phone: +49-3455525765

Fax: +49-3455525021

Email: Draeger@pharmazie.uni-halle.de

    >